Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2.
Jonathan FintziTyler BonnettPablo TebasMahomed-Yunus MoosaCorri B LevineHana M El SahlySusan L F McLellanConstance A BensonChristina A RostadAnuradha GanesanNikhil HuprikarMaria G FrankRichard A MularskiRobert L AtmarPauline K ParkWilliam R ShortJohn H BeigelAneesh K MehtaDaniel A SweeneyPublished in: Open forum infectious diseases (2022)
Compared with RMT, BCT reduces the clinical burden and utilization of intensive respiratory therapies for patients requiring low-flow oxygen or noninvasive positive-pressure ventilation compared with RMT and may thereby improve care for this patient population.